Triglyceride-Glucose Index In Heart Failure Patients In Sohag University Hospital

December 15, 2022 updated by: Aliaa Khairy Shabaan, Sohag University
study the relationship between Triglyceride glucose index and heart failure patients

Study Overview

Status

Recruiting

Conditions

Study Type

Observational

Enrollment (Anticipated)

200

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: Ali T Taha, professor

Study Locations

  • Egypt
      • Sohag, Egypt
        • Recruiting
        • Sohag university Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

17 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Patients will be divided into2 groups, as following:

Group (1) Heart Failure patients (100 patients) Group (2) control group(100 person)

All groups will be subjected to :

  1. Complete history taking with special emphasis on Age ,Sex, Smoking, Diabetes mellitus and Hypertension.
  2. A thorough clinical examination will stress on:

1- Heart rate (b.p.m.). 2-Systolic BP (mmHg). 3-BMI calculated as the ( weight (kg)/height (m)2). 3-The following investigations will be done to every subject:

  1. FBG (mg/dL)
  2. FTG, (mg/dL)
  3. Total cholesterol (TC) (mg/dL)
  4. SCr (mg/dL)
  5. Echocardiography

TyG index is calculated as ln [fasting triglyceride (mg/dL) * fasting glucose (mg/dL) / 2]

Description

Inclusion Criteria:

  • All Heart Failure patients attend to sohag university hospital aged above 18 year old .

Exclusion Criteria:

  • Patients on lipid lowering medications
  • Patients on antidiabetic drugs
  • Patients with comorbidities eg liver cirrhosis or malignancy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Control
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
group 1 heart failure patients
Group 2 controle

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Triglyceride-Glucose Index in Heart Failure Patients
Time Frame: 6 months
identify the relationship between Triglyceride-Glucose Index and heart failure patients in Sohag University hospital
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sohag University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 12, 2022

Primary Completion (Anticipated)

May 1, 2023

Study Completion (Anticipated)

June 1, 2023

Study Registration Dates

First Submitted

December 15, 2022

First Submitted That Met QC Criteria

December 15, 2022

First Posted (Estimate)

December 23, 2022

Study Record Updates

Last Update Posted (Estimate)

December 23, 2022

Last Update Submitted That Met QC Criteria

December 15, 2022

Last Verified

December 1, 2022

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Soh-Med-22-12-04

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Heart Failure

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bahrain

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe